Fennec Pharmaceuticals Inc. (FENC) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$9,690
Total Return
-3.10%
CAGR
-0.63%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.35% |
| Median | +0.69% |
| Best | +56.81% |
| Worst | -59.01% |
| % of Windows Positive | 52.4% |
1-Year (252 Trading Days)
| Average | +12.45% |
| Median | +3.05% |
| Best | +147.30% |
| Worst | -53.99% |
| % of Windows Positive | 53.9% |
3-Year (756 Trading Days)
| Average | +3.30% |
| Median | -0.15% |
| Best | +67.56% |
| Worst | -57.66% |
| % of Windows Positive | 49.5% |
Risk Metrics
| Maximum Drawdown | -65.63% |
| Average Drawdown | -28.63% |
| Drawdown Duration | 573 Trading Days (Unrecovered) |
| Sortino Ratio | 0.40 |
| Calmar Ratio | -0.01 |
| CVaR (5%) | -8.01% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -18.83% (-51.94% ann.) | $1883.13 | $0.00 | $0.00 | $0.00 |
| 2025 | +21.84% | +$2183.54 | $0.00 | $0.00 | $0.00 |
| 2024 | -43.67% | $4367.20 | $0.00 | $0.00 | $0.00 |
| 2023 | +16.87% | +$1687.50 | $0.00 | $0.00 | $0.00 |
| 2022 | +118.18% | +$11818.16 | $0.00 | $0.00 | $0.00 |
| 2021 | -40.94% | $4093.95 | $0.00 | $0.00 | $0.00 |
| 2020 | +14.79% | +$1479.20 | $0.00 | $0.00 | $0.00 |
| 2019 | +1.72% | +$172.40 | $0.00 | $0.00 | $0.00 |
| 2018 | -36.33% | $3632.73 | $0.00 | $0.00 | $0.00 |
| 2017 partial | -16.50% (-46.60% ann.) | $1650.00 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | September 15, 2017 – February 19, 2020 | -33.21% | -15.31% | $3320.83 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -35.06% | -99.28% | $3506.18 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +31.98% | +56.28% | +$3197.87 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -40.62% | -39.01% | $4062.11 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | +88.61% | +96.15% | +$8861.07 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -35.70% | -21.20% | $3569.69 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +19.73% | +12.16% | +$1973.17 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.